The first fixed-dose combination pill containing 3 drugs has been approved for use in the United States by the US Food and Drug Administration (FDA). Exforge HCT®, which is marketed by Novartis, ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Exforge HCT contains the active ingredients Amlodipine Besilate, ...
The FDA has approved Novartis’ Diovan HCT (valsartan/hydrochlorothiazide tablets) and Exforge (amlodipine/valsartan tablets) as first-line therapies for hypertension in patients likely to need ...
Yahoo Finance: Teva First to Launch a Generic of Novartis' Exforge HCT
With Teva being the first to file, the company will enjoy 180 days of marketing exclusivity. As per IMS data, Exforge HCT tablets recorded annual sales of approximately $158 million in the U.S. as of ...
The FDA has approved Novartis‘ Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) tablets, a combination product containing a calcium channel blocker, an ...
FierceBiotech: Single-pill combinations Diovan HCT® and Exforge® approved in US as first-line treatments for high blood pressure
Single-pill combinations Diovan HCT® and Exforge® approved in US as first-line treatments for high blood pressure
Nasdaq: Teva First to Launch a Generic of Novartis' Exforge HCT - Analyst Blog
Teva Pharmaceutical Industries Limited ( TEVA) has launched its generic version of Novartis' ( NVS) Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) tablets in the U.S. Exforge HCT is approved ...
Teva First to Launch a Generic of Novartis' Exforge HCT - Analyst Blog
FierceBiotech: Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure
EAST HANOVER, N.J., Aug. 4 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved two single-pill combination medications, Diovan HCT(R) (valsartan and hydrochlorothiazide) and Exforge ...